Goodwin Procter LLP advised C4 Therapeutics on the deal. C4 Therapeutics, Inc. (Nasdaq: CCCC) announced its upsized initial public offering for gross proceeds of $209.76 million,…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Ambrogio Visconti
…
This content is for Standard 1 Year members only. LoginJoin Now